Quarterly report [Sections 13 or 15(d)]

Shareholders Equity (Details Narrative)

v3.25.2
Shareholders Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2023
Apr. 27, 2023
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Sep. 30, 2024
Cost of shares repurchased, including commissions and fees           $ 1,575  
Repurchased shares of common stock 6,129,000         2,717,000  
Issued and outstanding common shares repurchased, percentage           5.40%  
Restricted stock available to be granted under amended plan         4,005,000    
Stock options available to be granted under amended plan         2,812,000    
Restricted stock and stock options available to be granted under amended plan         6,817,000    
Restricted shares granted under AICP         48,000    
Board Of Directors Chairman [Member]              
Authorized amount for share repurchase program   $ 20,000          
2013 Incentive Stock Plan [Member]              
Stock options available to be granted under amended plan         7,500,000    
Shares authorized to be granted under amended plan         15,000,000    
Restricted stock available to be granted under amended Plan         7,500,000    
Stock options granted         1,550,000    
Warrant [Member]              
Weighted average remaining contractual life             6 months
Weighted average exercise price per share             $ 2
Warrants outstanding     0   0   77,000
Warrants [Member] | Stock Option [Member]              
Share-based compensation expense     $ 124 $ 71 $ 257 $ 229  
Unrecognized compensation expense     547   $ 547    
Weighted average remaining vesting period         2 years 11 months 12 days    
Restricted Stock [Member]              
Share-based compensation expense     53 $ 78 $ 161 $ 230  
Unrecognized compensation expense     $ 143   $ 143    
Weighted average remaining vesting period         8 months 23 days